Chen Wei, Xiang Hong, Chen Ruifang, Yang Jie, Yang Xiaoping, Zhou Jianda, Liu Hengdao, Zhao Shaoli, Xiao Jie, Chen Pan, Chen Alex F, Chen Shuhua, Lu Hongwei
Center for Experimental Medical Research, The Third Xiangya Hospital of Central South University, 138 Tongzipo Road, Changsha, Hunan, 410013, People's Republic of China.
Department of Cardiology, the Third Xiangya Hospital of Central South University, Changsha, Hunan, 410013, People's Republic of China.
BMC Nephrol. 2019 Apr 18;20(1):135. doi: 10.1186/s12882-019-1323-0.
Sphingosine-1-phosphate receptor 2 (S1PR2) is a G-protein-coupled receptor that regulates sphingosine-1-phosphate-triggered cellular response. However, the role of S1PR2 in diabetes-induced glomerular endothelial cell dysfunction remains unclear. This study aims to investigate the effect of S1PR2 blockade on the morphology and function of mitochondria in human renal glomerular endothelial cells (HRGECs).
HRGECs were pretreated with a S1PR2 antagonist (JTE-013) or a Rho-associated coiled coil-containing protein kinase 1 (ROCK1) inhibitor (Y27632) for 30 min and then cultured with normal glucose (5.5 mM) or high glucose (30 mM) for 72 h. The protein expression levels of RhoA, ROCK1, and Dynmin-related protein-1(Drp1) were evaluated by immunoblotting; mitochondrial morphology was observed by electron microscopy; intracellular levels of ATP, ROS, and Ca were measured by ATPlite, DCF-DA, and Rhod-2 AM assays, respectively. Additionally, the permeability, apoptosis, and migration of cells were determined to evaluate the effects of S1PR2 and ROCK1 inhibition on high glucose-induced endothelial dysfunction.
High glucose induced mitochondrial fission and dysfunction, indicated by increased mitochondrial fragmentation, ROS generation, and calcium overload but decreased ATP production. High glucose also induced endothelial cell dysfunction, indicated by increased permeability and apoptosis but decreased migration. However, inhibition of either S1PR2 or ROCK1 almost completely blocked these high glucose-mediated cellular responses. Furthermore, inhibiting S1PR2 resulted in the deceased expression of RhoA, ROCK1, and Drp1 while inhibiting ROCK1 led to the downregulated expression of Drp1.
S1PR2 antagonist modulates the morphology and function of mitochondria in HRGECs via the positive regulation of the RhoA/ROCK1/Drp1 signaling pathway, suggesting that the S1PR2/ROCK1 pathway may play a crucial role in high glucose milieu.
1-磷酸鞘氨醇受体2(S1PR2)是一种G蛋白偶联受体,可调节1-磷酸鞘氨醇触发的细胞反应。然而,S1PR2在糖尿病诱导的肾小球内皮细胞功能障碍中的作用仍不清楚。本研究旨在探讨阻断S1PR2对人肾小球内皮细胞(HRGECs)线粒体形态和功能的影响。
将HRGECs用S1PR2拮抗剂(JTE-013)或含Rho相关卷曲螺旋蛋白激酶1(ROCK1)抑制剂(Y27632)预处理30分钟,然后用正常葡萄糖(5.5 mM)或高葡萄糖(30 mM)培养72小时。通过免疫印迹评估RhoA、ROCK1和动力相关蛋白1(Drp1)的蛋白表达水平;通过电子显微镜观察线粒体形态;分别通过ATPlite、DCF-DA和Rhod-2 AM测定法测量细胞内ATP、活性氧(ROS)和钙的水平。此外,测定细胞的通透性、凋亡和迁移,以评估抑制S1PR2和ROCK1对高糖诱导的内皮功能障碍的影响。
高糖诱导线粒体分裂和功能障碍,表现为线粒体碎片化增加、ROS生成增加和钙超载,但ATP产生减少。高糖还诱导内皮细胞功能障碍,表现为通透性增加和凋亡增加,但迁移减少。然而,抑制S1PR2或ROCK1几乎完全阻断了这些高糖介导的细胞反应。此外,抑制S1PR2导致RhoA、ROCK1和Drp1的表达降低,而抑制ROCK1导致Drp1的表达下调。
S1PR2拮抗剂通过对RhoA/ROCK1/Drp1信号通路的正向调节来调节HRGECs中线粒体的形态和功能,提示S1PR2/ROCK1通路可能在高糖环境中起关键作用。